|
BASi, listed on Nasdaq, provides contract research services and unique monitoring instruments to the world
’s leading drug development companies. We concentrate on developing innovative services and products that increase
efficiency and reduce costs associated with taking new drugs to market. Our focus is on the future. We are involved in new
biomedical ventures that mankind has never attempted before, and we believe opportunities for the company’s products and
services are greater than ever.
SEC Filings | Section 16 Filings
Last trade:
|
Change: |
 0.02 |
Trade time: |
3:59pm ET |
$1.20 |
Open: |
1.25 |
Date: |
2/3/2012 |
| Volume: |
32,856 |
Day's range: |
1.15 - 1.26 |
Note: Some charts may be in logarithmic scale.
Data provided by Yahoo!Finance (Delayed 20 minutes).
Investor Relations
Neil G. Berkman Associates
11835 West Olympic Blvd.
Suite 405E
Los Angeles, California 90064
(310) 477-3118
nberkman@berkmanassociates.com
Our Registrar and Transfer Company is:
Computershare Investor Services
7530 Lucerne Drive, Suite 305
Cleveland, OH 44130
800.622.6757
www.computershare.com
|
